Literature DB >> 24879293

Interferon regulatory factor 3 in adaptive immune responses.

Laure Ysebrant de Lendonck1, Valerie Martinet, Stanislas Goriely.   

Abstract

Interferon regulatory factor (IRF) 3 plays a key role in innate responses against viruses. Indeed, activation of this transcription factor triggers the expression of type I interferons and downstream interferon-stimulated genes in infected cells. Recent evidences indicate that this pathway also modulates adaptive immune responses. This review focuses on the different mechanisms that are implicated in this process. We discuss the role of IRF3 within antigen-presenting cells and T lymphocytes in the polarization of the cellular immune response and its implication in the pathogenesis of immune disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24879293     DOI: 10.1007/s00018-014-1653-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  105 in total

1.  The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Authors:  Pengyuan Yang; Huazhang An; Xingguang Liu; Mingyue Wen; Yuanyuan Zheng; Yaocheng Rui; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

2.  Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.

Authors:  Melanie Wiesel; Josh Crouse; Gregor Bedenikovic; Andrew Sutherland; Nicole Joller; Annette Oxenius
Journal:  Eur J Immunol       Date:  2011-12-20       Impact factor: 5.532

3.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

4.  A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT.

Authors:  B Martín-Antonio; M Suarez-Lledo; M Arroyes; F Fernández-Avilés; C Martínez; M Rovira; I Espigado; D Gallardo; A Bosch; I Buño; C Martínez-Laperche; A Jiménez-Velasco; R de la Cámara; S Brunet; J B Nieto; A Urbano-Ispizua
Journal:  Bone Marrow Transplant       Date:  2013-04-01       Impact factor: 5.483

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  IRF3-dependent type I interferon response in B cells regulates CpG-mediated antibody production.

Authors:  Gagik Oganesyan; Supriya K Saha; Eric M Pietras; Beichu Guo; Andrea K Miyahira; Brian Zarnegar; Genhong Cheng
Journal:  J Biol Chem       Date:  2007-10-09       Impact factor: 5.157

7.  Activation of MDA5 requires higher-order RNA structures generated during virus infection.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon-Ping Tan; Jan Rehwinkel; Hiroki Kato; Osamu Takeuchi; Shizuo Akira; Michael Way; Giampietro Schiavo; Caetano Reis e Sousa
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

8.  The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response.

Authors:  Kislay Parvatiyar; Zhiqiang Zhang; Rosane M Teles; Songying Ouyang; Yan Jiang; Shankar S Iyer; Shivam A Zaver; Mirjam Schenk; Shang Zeng; Wenwan Zhong; Zhi-Jie Liu; Robert L Modlin; Yong-jun Liu; Genhong Cheng
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

9.  Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.

Authors:  Denise C Fitzgerald; Zoë Fonseca-Kelly; Melissa L Cullimore; Pegah Safabakhsh; Christiaan J M Saris; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

10.  IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo.

Authors:  Gabriel R Starbeck-Miller; Hai-Hui Xue; John T Harty
Journal:  J Exp Med       Date:  2013-12-23       Impact factor: 14.307

View more
  18 in total

Review 1.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

2.  The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.

Authors:  A de Laurentiis; J Hiscott; M Alcalay
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

3.  Development and Evaluation of a Bicistronic DNA Vaccine against Nervous Necrosis Virus in Pearl Gentian Grouper (Epinephelus lanceolatus × Epinephelus fuscoguttatus).

Authors:  Tianwen Lin; Jing Xing; Xiaoqian Tang; Xiuzhen Sheng; Heng Chi; Wenbin Zhan
Journal:  Vaccines (Basel)       Date:  2022-06-14

4.  Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells.

Authors:  Ming-ming Ni; Tao Xu; Ya-rui Wang; Ying-hua He; Qun Zhou; Cheng Huang; Xiao-ming Meng; Jun Li
Journal:  J Physiol Biochem       Date:  2015-11-26       Impact factor: 4.158

5.  Attenuation of interferon regulatory factor 7 activity in local infectious sites of trachea and lung for preventing the development of acute lung injury caused by influenza A virus.

Authors:  Lei Yang; Liqun Tu; Peiyan Zhao; Ying Wang; Shengnan Wang; Wenting Lu; Yangyang Wang; Xin Li; Yongli Yu; Shucheng Hua; Liying Wang
Journal:  Immunology       Date:  2019-02-27       Impact factor: 7.397

6.  Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice.

Authors:  Hideyuki Yanai; Shiho Chiba; Sho Hangai; Kohei Kometani; Asuka Inoue; Yoshitaka Kimura; Takaya Abe; Hiroshi Kiyonari; Junko Nishio; Naoko Taguchi-Atarashi; Yu Mizushima; Hideo Negishi; Rudolf Grosschedl; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

7.  Genetic Variation of Goat Interferon Regulatory Factor 3 Gene and Its Implication in Goat Evolution.

Authors:  Moses Okpeku; Ali Esmailizadeh; Adeniyi C Adeola; Liping Shu; Yesheng Zhang; Yangzi Wang; Timothy M Sanni; Ikhide G Imumorin; Sunday O Peters; Jiajin Zhang; Yang Dong; Wen Wang
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

Review 8.  The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection.

Authors:  Bowen Wang; Wen Kang; Jiahui Zuo; Wenzhen Kang; Yongtao Sun
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

9.  AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300.

Authors:  Shengyu Wang; Xin Sun; Chenyang Yi; Dan Zhang; Xian Lin; Xiaomei Sun; Huanchun Chen; Meilin Jin
Journal:  Front Cell Infect Microbiol       Date:  2017-05-22       Impact factor: 5.293

10.  Activation of Vago by interferon regulatory factor (IRF) suggests an interferon system-like antiviral mechanism in shrimp.

Authors:  Chaozheng Li; Haoyang Li; Yixiao Chen; Yonggui Chen; Sheng Wang; Shao-Ping Weng; Xiaopeng Xu; Jianguo He
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.